Novo Nordisk A S (NVO)

Current price: $40.00

These defaults work well for most companies. Only adjust them if you have a specific view on this business's risk profile or long-term growth prospects.

Discount Rate

Your required annual return on investmentTerminal Growth Rate

Long-run growth rate beyond projection period (≤ GDP growth)

Graham Number

√(22.5 × EPS × Book Value per Share)

$150.42

+276% upside

Earnings Power Value

Normalized after-tax earnings ÷ required return (zero-growth)

$140.53

+251% upside

DCF Fair Value

Projected free cash flow discounted to present value + terminal value

Not applicable

Insufficient history: requires at least 3 years of free cash flow (found 0).

P/E Fair Value

Earnings per share × target P/E multiple

$345.45

+764% upside

Target P/E Multiple

What multiple do you think is fair for this business?

Valuation estimates are models, not investment advice. They are highly sensitive to the assumptions chosen and carry significant uncertainty. Past fundamentals do not guarantee future performance.